Comparison Chart Evotec SE Deutsche Boerse AG
Stocks
EVTA
US30050E1055
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.690 EUR | -15.50% |
|
-28.99% | -35.98% |
| 07:35am | TD Cowen Downgrades Evotec to Hold From Buy, Adjusts Price Target to $2 From $4 | MT |
| 07-14 | Evotec SE, Q2 2026 Earnings Call, Jul 14, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC SE | Other Biotechnology & Medical Research | -15.50% | -28.99% | -35.98% | -50.29% | -90.74% | 763M |
-
|
-
|
-
|
- Stock Market
- Stocks
- EVT Stock
- EVTA Stock
- Charts Evotec SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















